Which at-risk patient groups remain largely unaware of preexposure prophylaxis (PrEP) against HIV infection?

Updated: Oct 08, 2019
  • Author: Alejandro Delgado, MD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print


It is estimated that approximately 25% of MSM and 19% of injection drug users would be eligible for daily PrEP. [28] Despite these numbers and some signs of overall progress in engaging eligible patients in care, [29] a significant number of at-risk patients remain unware of PrEP availability. This is especially true in some of the most at-risk populations, such as black MSM. [30] Continuing efforts in provider education are paramount for successful implementation of these programs.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!